Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials-Reference-Cited by-同舟云学术

Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials

Published:2001-10 Issue:1 Volume:34 Page:29-36
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ichinose Yukito,Kato Harubumi,Koike Teruaki,Tsuchiya Ryosuke,Fujisawa Takehiko,Shimizu Nobuyoshi,Watanabe Yoh,Mitsudomi Tetsuya,Yoshimura Masahiro

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. The role of surgery in N2 lung cancer;Martini;Surg. Clin. North Am.,1987

2. Aggressive surgical intervention in N2 non-small cell lung cancer of the lung;Watanabe;Ann. Thorac. Surg.,1991

3. Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease);Goldstraw;J. Thorac. Cardiocvasc. Surg.,1994

4. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases;Vansteenkiste;Ann. Thorac. Surg.,1997

5. Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature;Vansteenkiste;Lung Cancer,1998

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival outcome of upfront surgery for clinical single-station N2 non-small cell lung cancer;Japanese Journal of Clinical Oncology;2023-01-18

2. Predictive Risk Factors for Early Recurrence of Stage pIIIA-N2 Non-Small Cell Lung Cancer;Cancer Management and Research;2021-11

3. The Impact of Skip vs. Non-Skip N2 Lymph Node Metastasis on the Prognosis of Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis;Frontiers in Surgery;2021-10-12

4. Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database;Thoracic Cancer;2021-03-16

5. Supraclavicular Recurrence in Completely Resected (y)pN2 Non-Small Cell Lung Cancer: Implications for Postoperative Radiotherapy;Frontiers in Oncology;2020-08-11